Relmada Therapeutics Inc (OTCMKTS:RLMD) Slips Again
The last time we covered Relmada Therapeutics Inc (OTCMKTS:RLMD) was back in April when the ticker had embarked on an upward run that could have pushed it to $4 per share. Unfortunately, that didn’t...